A U.S. appeals court has revived a lawsuit initiated by a conservative group that opposes diversity initiatives in medicine. The lawsuit targets a Pfizer fellowship program designed to enhance the representation of Black, Latino, and Native American individuals in leadership roles within the medical field. The ruling allows the challenge to proceed, highlighting ongoing debates surrounding diversity programs in healthcare. The case has garnered attention as it reflects broader societal discussions about diversity and inclusion in professional settings.